Celltrion Pharm Inc. Stock Price & Chart

KRX: 068760 · 셀트리온제약 · KOSPI

₩39,900▼ ₩950 (-2.33%)at close · July 28, 2026
78,30037,80039,900Jul 04, 25Oct 13Jan 15Apr 21Jul 28, 26

Celltrion Pharm Inc. (셀트리온제약, KRX: 068760) last closed at ₩39,900 on July 28, 2026, a -2.33% move on the day. Over the trailing 52 weeks the stock has traded between ₩37,800 and ₩78,300, a -22.94% change over the past year. Figures are end-of-day closing prices from the Korea Exchange.

Last close₩39,900
Day change-2.33%
52-week high₩78,300
52-week low₩37,800

Key Fundamentals

FY 2025.09
Market cap₩1.77T
P/E (PER)0.00
P/B (PBR)0.00
EPS₩0
BPS₩0
ROE0.00%
Debt ratio0.00%
Rev. growth0.00%

P/E, P/B and market cap are computed from the latest close; EPS, BPS, ROE and debt ratio are the most recent reported figures (FY 2025.09) from the Korea Investment & Securities Open API. Informational only, not investment advice.

Technical Snapshot

as of 2026-07-28
BearishAlgorithmic summary of 5 standard indicators (net score -3). Describes current technical posture only — not a buy or sell recommendation.
  • ▼ Bearish20-day MAPrice below 40,245
  • ▼ Bearish60-day MAPrice below 44,903
  • ▼ Bearish120-day MAPrice below 53,931
  • ▼ BearishMA trend (20 vs 60)Short-term below mid-term
  • · NeutralRSI (14)RSI 41 — neutral zone
  • ▲ BullishMACD (12,26,9)MACD above signal
52-week position: 5% of rangeRSI(14): 415-day volume vs 20-day: +1%

Indicators are computed mechanically from end-of-day prices. They are provided for informational purposes only, are not investment advice or a recommendation, and past performance does not indicate future results.

Reports mentioning Celltrion Pharm Inc.

No daily reports have covered Celltrion Pharm Inc. yet. New reports appear here automatically when the stock is featured.

← Back to all Korean stocks

Price history is sourced from the Korea Exchange via the Korea Investment & Securities Open API and updated after each trading session. This page is provided for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data may be delayed or contain errors — verify with an official source before trading.